14 patents
Utility
Highly Water-soluble Salts of a Short Acting Phenylalkylamine Calcium Channel Blocker and Uses Thereof
28 Dec 23
The present invention includes surprisingly water-soluble salts of a phenylalkylamine compound that are potent antagonists of L-type calcium channels.
Martin P. MAGUIRE
Filed: 6 Sep 23
Utility
Short Acting Phenylalkylamine Calcium Channel Blockers and Uses Thereof
17 Aug 23
The present invention relates to the use of a pharmaceutically effective amount of an short-acting calcium channel blocking compound to treat ischemic heart conditions, cardiac arrhythmias, hypertensive crisis in an emergency room setting, hypertension before, during, or after surgery, no-reflow phenomenon following reperfusion, and diseases associated with decreased skeletal muscle blood flow.
Martin P. MAGUIRE, Elise RIOUX, Harry J. LEIGHTON
Filed: 24 Apr 23
Utility
Highly Water-soluble Salts of a Short Acting Phenylalkylamine Calcium Channel Blocker and Uses Thereof
25 May 23
The present invention includes surprisingly water-soluble salts of a phenylalkylamide compound that are potent antagonists of L-type, calcium channels.
Martin P. MAGUIRE
Filed: 13 Jan 23
Utility
Methods of Administration for Highly Water-soluble Salts of a Short Acting Phenylalkylamine Calcium Channel Blocker
2 Mar 23
Francis PLAT, Douglas WIGHT
Filed: 15 Jul 22
Utility
Highly Water-soluble Salts of a Short Acting Phenylalkylamine Calcium Channel Blocker and Uses Thereof
22 Sep 22
The present invention includes surprisingly water-soluble salts of a phenylalkylamine compound that are potent antagonists of L-type calcium channels.
Martin P. MAGUIRE
Filed: 2 Jun 22
Utility
Short Acting Phenylalkylamine Calcium Channel Blockers and Uses Thereof
12 May 22
The present invention relates to the use of a pharmaceutically effective amount of an short-acting calcium channel blocking compound to treat ischemic heart conditions, cardiac arrhythmias, hypertensive crisis in an emergency room setting, hypertension before, during, or after surgery, no-reflow phenomenon following reperfusion, and diseases associated with decreased skeletal muscle blood flow.
Martin P. MAGUIRE, Elise RIOUX, Harry J. LEIGHTON
Filed: 26 Jan 22
Utility
Highly Water-soluble Salts of a Short Acting Phenylalkylamine Calcium Channel Blocker and Uses Thereof
10 Feb 22
The present invention includes surprisingly water-soluble salts of a phenylalkylamine compound that are potent antagonists of L-type calcium channels.
Martin P. MAGUIRE
Filed: 26 Oct 21
Utility
Short Acting Phenylalkylamine Calcium Channel Blockers and Uses Thereof
14 Oct 21
The present invention relates to the use of a pharmaceutically effective amount of an short-acting calcium channel blocking compound to treat ischemic heart conditions, cardiac arrhythmias, hypertensive crisis in an emergency room setting, hypertension before, during, or after surgery, no-reflow phenomenon following reperfusion, and diseases associated with decreased skeletal muscle blood flow.
Martin P. MAGUIRE, Elise RIOUX, Harry J. LEIGHTON
Filed: 22 Jun 21
Utility
Highly Water-soluble Salts of a Short Acting Phenylalkylamine Calcium Channel Blocker and Uses Thereof
8 Jul 21
The present invention includes surprisingly water-soluble salts of a phenylalkylamine compound that are potent antagonists of L-type calcium channels.
Martin P. MAGUIRE
Filed: 18 Mar 21
Utility
Short Acting Phenylalkylamine Calcium Channel Blockers and Uses Thereof
4 Mar 21
The present invention relates to the use of a pharmaceutically effective amount of an short-acting calcium channel blocking compound to treat ischemic heart conditions, cardiac arrhythmias, hypertensive crisis in an emergency room setting, hypertension before, during, or after surgery, no-reflow phenomenon following reperfusion, and diseases associated with decreased skeletal muscle blood flow.
Martin P. MAGUIRE, Elise RIOUX, Harry J. LEIGHTON
Filed: 12 Nov 20
Utility
Highly Water-soluble Salts of a Short Acting Phenylalkylamine Calcium Channel Blocker and Uses Thereof
25 Nov 20
The present invention includes surprisingly water-soluble salts of a phenylalkylamine compound that are potent antagonists of L-type calcium channels.
Martin P. MAGUIRE
Filed: 12 Aug 20
Utility
Short Acting Phenylalkylamine Calcium Channel Blockers and Uses Thereof
22 Jul 20
The present invention relates to the use of a pharmaceutically effective amount of an short-acting calcium channel blocking compound to treat ischemic heart conditions, cardiac arrhythmias, hypertensive crisis in an emergency room setting, hypertension before, during, or after surgery, no-reflow phenomenon following reperfusion, and diseases associated with decreased skeletal muscle blood flow.
Martin P. MAGUIRE, Elise RIOUX, Harry J. LEIGHTON
Filed: 8 Apr 20
Utility
Highly Water-soluble Salts of a Short Acting Phenylalkylamine Calcium Channel Blocker and Uses Thereof
22 Apr 20
The present invention includes surprisingly water-soluble salts of a phenylalkylamine compound that are potent antagonists of L-type calcium channels.
Martin P. Maguire
Filed: 18 Dec 19
Utility
Short Acting Phenylalkylamine Calcium Channel Blockers and Uses Thereof
18 Dec 19
The present invention relates to the use of a pharmaceutically effective amount of an short-acting calcium channel blocking compound to treat ischemic heart conditions, cardiac arrhythmias, hypertensive crisis in an emergency room setting, hypertension before, during, or after surgery, no-reflow phenomenon following reperfusion, and diseases associated with decreased skeletal muscle blood flow.
Martin P. MAGUIRE, Elise RIOUX, Harry J. LEIGHTON
Filed: 28 Aug 19
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first